Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medikinet retard in Chinese children and adolescents with ADHD
CTR20180056Phase 3Completed
- Sponsor
- Medice
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Medice. Started May 2018; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on CTR20180056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180056.